David L. GreenwoodChairman
Mr. Greenwood is the former President, Chief Executive Officer, Chief Financial Officer and Director of Geron Corporation. He was previously Chairman of Geron’s wholly-owned subsidiary, Geron Bio-Med Limited, Chairman of Geron’s majority-owned subsidiary, TA Therapeutics, Ltd., and a Director of ViaGen, Inc., Clone International and Parnell Pharmaceuticals Holdings Ltd. He also served on the Board of Regents for Pacific Lutheran University. From 1979 until joining Geron, Mr. Greenwood held various positions with J.P. Morgan & Co. Incorporated, an international banking firm. Mr. Greenwood holds a B.A. from Pacific Lutheran University and a M.B.A. from Harvard Business School.